COVID-19 vaccines: implementation, limitations and opportunities
DD Richman - Global Health & Medicine, 2021 - jstage.jst.go.jp
The speed of development and the magnitude of efficacy of recently developed vaccines
directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize …
directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize …
[HTML][HTML] The COVID-19 vaccines: recent development, challenges and prospects
Y Yan, Y Pang, Z Lyu, R Wang, X Wu, C You, H Zhao… - Vaccines, 2021 - mdpi.com
The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
[HTML][HTML] What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …
has caused more than 1 million deaths in the first 6 months of the pandemic and huge …
Insight into the Advances in Clinical Trials of SARS‐CoV‐2 Vaccines
SM Basheeruddin Asdaq, S Jomah… - Canadian Journal of …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has thrown a challenge to
the scientific community. Several interventions to stop or limit the spread of infection have …
the scientific community. Several interventions to stop or limit the spread of infection have …
COVID-19 Vaccines—All You Want to Know
AA Shishido, AH Barnes, S Narayanan… - … in Respiratory and …, 2023 - thieme-connect.com
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic has led to
an unprecedented public health crisis. The collective global response has led to production …
an unprecedented public health crisis. The collective global response has led to production …
COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …
[HTML][HTML] Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines
There are currently around 200 SARS-CoV-2 candidate vaccines in preclinical and clinical
trials throughout the world. The various candidates employ a range of vaccine strategies …
trials throughout the world. The various candidates employ a range of vaccine strategies …
Efficacy of COVID-19 vaccines: From clinical trials to real life
D Deplanque, O Launay - Therapies, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around
the globe leading to the COVID-19 pandemic. To mitigate the effects of the virus on public …
the globe leading to the COVID-19 pandemic. To mitigate the effects of the virus on public …
[HTML][HTML] Efforts at COVID-19 vaccine development: challenges and successes
A Haque, AB Pant - Vaccines, 2020 - mdpi.com
The rapid spread of SARS-CoV-2, the new coronavirus (CoV), throughout the globe poses a
daunting public health emergency. Different preventive efforts have been undertaken in …
daunting public health emergency. Different preventive efforts have been undertaken in …
[HTML][HTML] COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
AA Zasada, A Darlińska, A Wiatrzyk, K Woźnica… - Viruses, 2023 - mdpi.com
The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …
It became clear that the development of an effective vaccine was the only way to stop the …